Posterior reversible encephalopathy syndrome

Handbook of Clinical Neurology

Volumn 121, Issue , 2014, Pages 1687-1701

  Lamy, C ^a   Oppenheim, C ^a   Mas, J L ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Cerebral edema; Hypertensive encephalopathy; Immunosuppressive drugs; Magnetic resonance imaging; Posterior leukoencephalopathy; Reversible posterior encephalopathy

Indexed keywords

ADULT; ARTICLE; BRAIN EDEMA; FEMALE; HUMAN; HYPERTENSION ENCEPHALOPATHY; IMMUNOSUPPRESSIVE DRUGS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PATHOPHYSIOLOGY; POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME; PREGNANCY; RADIOGRAPHY; REVERSIBLE POSTERIOR ENCEPHALOPATHY;

CEREBRAL EDEMA; HYPERTENSIVE ENCEPHALOPATHY; IMMUNOSUPPRESSIVE DRUGS; MAGNETIC RESONANCE IMAGING; POSTERIOR LEUKOENCEPHALOPATHY; REVERSIBLE POSTERIOR ENCEPHALOPATHY;

POSTERIOR LEUKOENCEPHALOPATHY SYNDROME; ADULT; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; NEUROIMAGING; PREGNANCY;

EID: 84890839196     PISSN: 00729752     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-7020-4088-7.00109-7     Document Type: Chapter

References (124)

1. Adhiyaman V., Alexander S. Cerebral hyperperfusion syndrome following carotid endarterectomy. QJM 2007, 100:239-244.
2. Allen J.A., Adlakha A., Bergethon P.R. Reversible posterior leukoencephalopathy syndrome after bevacizumab/FOLFIRI regimen for metastatic colon cancer. Arch. Neurol. 2006, 63:1475-1478.
3. Andreux F., Marro B., El Khoury N., et al. Reversible encephalopathy associated with cholesterol embolism syndrome: magnetic resonance imaging and pathological findings. J. Neurol. Neurosurg Psychiatry 2007, 78:180-182.
4. Ay H., Buonanno F., Schaefer P., et al. Posterior leukoencephalopathy without severe hypertension. Utility of diffusion-weighted MRI. Neurology 1998, 51:1369-1376.
5. Bakshi R., Bates V., Mechtler L., et al. Occipital seizures as the major clinical manifestation of reversible posterior leukoencephalopathy syndrome: magnetic resonance imaging findings. Epilepsia 1998, 39:296-299.
6. Bartynski W.S. Posterior reversible encephalopathy syndrome part 1: fundamental imaging and clinical features. AJNR Am. J. Neuroradiol 2008, 29:1036-1042.
7. Bartynski W.S. Posterior reversible encephalopathy syndrome part 2: controversies surrounding pathophysiology of vasogenic edema. AJNR Am. J. Neuroradiol 2008, 29:1043-1049.
8. Bartynski W.S., Boardman J.F. Distinct imaging patterns and lesion distribution in posterior reversible encephalopathy syndrome. AJNR Am. J. Neuroradiol 2007, 28:1320-1327.
9. Bartynski W.S., Boardman J.F. Catheter angiography MR angiography and MR perfusion in posterior reversible encephalopathy syndrome. AJNR Am. J. Neuroradiol 2008, 29:447-455.
10. Bartynski W.S., Boardman J.F., Zeigler Z.R., et al. Posterior reversible encephalopathy syndrome in infection sepsis and shock. AJNR Am. J. Neuroradiol 2006, 27:2179-2190.
11. Bartynski W.S., Tan H.P., Boardman J.F., et al. Posterior reversible encephalopathy syndrome after solid organ transplantation. AJNR Am. J. Neuroradiol 2008, 29:924-930.
12. Beausang-Linder M., Bill A. Cerebral circulation in acute arterial hypertension-protective effect of sympathetic nervous activity. Acta. Physiol. Scand 1981, 111:193-199.
13. Bellamy L., Casas J.P., Hingorani A.D., et al. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ 2007, 335:974.
14. Besenski N., Rumboldt Z., Emovon O., et al. Brain MR imaging abnormalities in kidney transplant recipients. AJNR Am. J. Neuroradiol 2005, 26:2282-2289.
15. Bill A., Linder J. Sympathetic control of cerebral blood flow in acute arterial hypertension. Acta. Physiol. Scand 1976, 96:114-121.
16. Black K.S., Mirsky P., Kalina P., et al. Angiographic demonstration of reversible cerebral vasospasm in porphyric encephalopathy. AJNR Am. J. Neuroradiol 1995, 16:1650-1652.
17. Bodkin C.L., Eidelman B.H. Sirolimus-induced posterior reversible encephalopathy. Neurology 2007, 68:2039-2040.
18. Boughammoura A., Touzé E., Oppenheim C., et al. Reversible angiopathy and encephalopathy after blood transfusion. J. Neurol. 2003, 250:116-118.
19. Burrus T.M., Mokri B., Rabinstein A.A., et al. A PRESsing dissection. Neurocrit Care 2010, 13:411-413.
20. Casey S.O., Truwit C.L. Pontine reversible edema: a newly recognized imaging variant of hypertensive encephalopathy?. AJNR Am. J. Neuroradiol 2000, 21:243-245.
21. Casey S.O., Sampaio R.C., Michel E., et al. Posterior reversible encephalopathy syndrome: utility of fluid-attenuated inversion recovery MR imaging in the detection of cortical and subcortical lesions. AJNR Am. J. Neuroradiol 2000, 21:1199-1206.
22. Chester E.M., Agamanolis D.P., Banker B.Q., et al. Hypertensive encephalopathy: a clinicopathologic study of 20 cases. Neurology 1978, 28:928-939.
23. Chester E.M., Agamanolis D.P., Banker B.Q., et al. Hypertensive encephalopathy: a clinicopathologic study of 20 cases. Neurology 1978, 28:928-939.
24. Christophe J.L., Plaen J.F.D., Goffette P., et al. Severe hypertension and renal infarct. Physiopatholgy and treatment. Nephrologie 1993, 14:133-137.
25. Coley S.C., Porter D.A., Calamante F., et al. Quantitative MR diffusion mapping and cyclosporine induced neurotoxicity. AJNR Am. J. Neuroradiol 1999, 20:1507-1510.
26. Covarrubias D.J., Luetmer P.H., Campeau N.G. Posterior reversible encephalopathy syndrome: prognostic utility of quantitative diffusion-weighted MR images. AJNR Am. J. Neuroradiol 2002, 23:1038-1048.
27. Cruz-Flores S., Assis Aquino G.F., Leira E.C. Brainstem involvement in hypertensive encephalopathy: clinical and radiological findings. Neurology 2004, 62:1417-1419.
28. Cumurciuc R., Martinez-Almoyna L., Henry C., et al. Posterior reversible encephalopathy syndrome during sunitinib therapy. Rev. Neurol. (Paris) 2008, 164:605-607.
29. Delanty N., Vaughan C., Frucht S., et al. Erythropoietin-associated hypertensive posterior leukoencephalopathy. Neurology 1997, 49:686-689.
30. Delefosse D., Samain E., Helias A., et al. Late onset of cortical blindness in a patient with severe preeclampsia related to retained placental fragments. Anesthesiology 2003, 98:261-263.
31. Digre K.B., Varner M.W., Osborn A.G., et al. Cranial magnetic resonance imaging in severe preeclampsia vs eclampsia. Arch. Neurol. 1993, 50:399-406.
32. Dinsdale H.B. Hypertensive encephalopathy. Stroke 1982, 13:717-719.
33. Ducros A., Boukobza M., Porcher R., et al. The clinical and radiological spectrum of reversible cerebral vasoconstriction syndrome. A prospective series of 67 patients. Brain 2007, 130:3091-3101.
34. Eichler F.S., Wang P., Wityk R.J., et al. Diffuse metabolic abnormalities in reversible posterior leukoencephalopathy syndrome. AJNR Am. J. Neuroradiol 2002, 23:833-837.
35. Elahi A., Kelkar P., St Louis E.K. Posterior reversible encephalopathy syndrome as the initial manifestation of Guillain-Barré syndrome. Neurocrit Care 2004, 1:465-468.
36. Engelter S.T., Provenzale J.M., Petrella J.R. Assessment of vasogenic edema in eclampsia using diffusion imaging. Neuroradiology 2000, 42:818-820.
37. Euser A.G., Cipolla M.J. Cerebral blood flow autoregulation and edema formation during pregnancy in anesthetized rats. Hypertension 2007, 49:334-340.
38. Friese S., Fetter M., Kuker W. Extensive brainstem edema in eclampsia: diffusion-weighted MRI may indicate a favorable prognosis. J. Neurol. 2000, 247:465-466.
39. Fugate J.E., Claassen D.O., Cloft H.J., et al. Posterior reversible encephalopathy syndrome: associated clinical and radiologic findings. Mayo. Clin. Proc. 2010, 85:427-432.
40. Giner V., Fernandez C., Esteban M.J., et al. Reversible posterior leukoencephalopathy secondary to indinavir-induced hypertensive crisis: a case report. Am. J. Hypertens 2002, 15:465-467.
41. Glusker P., Recht L., Lane B. Reversible posterior leukoencephalopathy syndrome and bevacizumab. N. Engl. J. Med. 2006, 354:980-982.
42. Grewal R.P., Miller B.L. Cocaine-induced hypertensive encephalopathy. Acta. Neurol. (Napoli) 1991, 13:279-281.
43. Gumus H., Per H., Kumandas S., et al. Reversible posterior leukoencephalopathy syndrome in childhood: report of nine cases and review of the literature. Neurol. Sci. 2010, 31:125-131.
44. Heistad D.D. What's new in the cerebral microcirculation?. Microcirculation 2001, 8:365-375.
45. Henderson R.D., Rajah T., Nicol A.J., et al. Posterior leukoencephalopathy following intrathecal chemotherapy with MRA-documented vasospasm. Neurology 2003, 60:326-328.
46. Heo K., Park S.A., Lee J.Y., et al. Post-transfusion posterior leukoencephalopathy with cytotoxic and vasogenic edema precipitated by vasospasm. Cerebrovasc Dis 2003, 15:230-233.
47. Hinchey J.A. Reversible posterior leukoencephalopathy syndrome: what have we learned in the last 10 years?. Arch. Neurol. 2008, 65:175-176.
48. Hinchey J., Chaves C., Appignani B., et al. A reversible posterior leukoencephalopathy syndrome. N. Engl. J. Med. 1996, 334:494-500.
49. Hurwitz R.L., Mahoney D.H., Armstrong D.L., et al. Reversible encephalopathy and seizures as a result of conventional vincristine administration. Med. Pediatr. Oncol. 1988, 16:216-219.
50. Ito Y. Post-transfusion reversible posterior leukoencephalopathy syndrome with cerebral vasoconstriction 1997.
51. Ito Y., Niwa H., Iida T., et al. Post-transfusion reversible posterior leukoencephalopathy syndrome with cerebral vasoconstriction. Neurology 1997, 49:1174-1175.
52. Jones B.V., Egelhoff J.C., Patterson R.J. Hypertensive encephalopathy in children. AJNR Am. J. Neuroradiol 1997, 18:101-106.
53. Kaplan P. Reversible hypercalcemic cerebral vasoconstriction with seizures and blindness: paradigm for eclampsia?. Clin Electrencephalogr 1998, 29:120-123.
54. Karapanayiotides T., Meuli R., Devuyst G., et al. Postcarotid endarterectomy hyperperfusion or reperfusion syndrome. Stroke 2005, 36:21-26.
55. Kelly K., Kalachand R., Murphy P. Bortezomib-induced reversible posterior leucoencephalopathy syndrome. Br. J. Haematol 2008, 141:566.
56. Keswani S.C., Wityk R. Don't throw in the towel! A case of reversible coma. J. Neurol. Neurosurg Psychiatry 2002, 73:83-84.
57. Keyserling H.F., Provenzale J.M. Atypical imaging findings in a near-fatal case of posterior reversible encephalopathy syndrome in a child. AJR Am. J. Roentgenol 2007, 188:219-221.
58. Koch S., Rabinstein A., Falcone S., et al. Diffusion-weighted imaging shows cytotoxic and vasogenic edema in eclampsia. AJNR Am. J. Neuroradiol 2001, 22:1068-1070.
59. Kupferschmidt H., Bont A., Schnorf H., et al. Transient cortical blindness and bioccipital brain lesions in two patients with acute intermittent porphyria. Ann. Intern. Med. 1995, 123:598-600.
60. Lamy C., Mas J.L. Hypertensive encephalopathy. Stroke: Pathophysiology, Diagnosis and Management 2011, 641-647. Elsevier, Philadelphia. J.P. Mohr, M.D. Philip, A. Wolf (Eds.).
61. Lamy C., Oppenheim C., Meder J.F., et al. Neuroimaging in posterior reversible encephalopathy syndrome. J. Neuroimaging 2004, 14:89-96.
62. Lee V.H., Wijdicks E.F., Manno E.M., et al. Clinical spectrum of reversible posterior leukoencephalopathy syndrome. Arch. Neurol. 2008, 65:205-210.
63. Leniger T., Kastrup O., Diener H.C. Reversible posterior leukoencephalopathy syndrome induced by granulocyte stimulating factor filgrastim. J. Neurol. Neurosurg Psychiatry 2000, 69:280-281.
64. Lewis L.K., Hinshaw D.B., Will A.D., et al. CT and angiographic correlation of severe neurological disease in toxemia of pregnancy. Neuroradiology 1988, 30:59-64.
65. Lin J.T., Wang S.J., Fuh J.L., et al. Prolonged reversible vasospasm in cyclosporin A-induced encephalopathy. AJNR Am. J. Neuroradiol 2003, 24:102-104.
66. Lin K.L., Hsu W.C., Wang H.S., et al. Hypertension-induced cerebellar encephalopathy and hydrocephalus in a male. Pediatr. Neurol. 2006, 34:72-75.
67. Malow B.A., Sandson T.A., Schwartz R.B. Reversible MRI lesions in eclampsia with hydatidiform mole. Neurology 1990, 40:1471-1472.
68. Manfredi M., Beltramello A., Bongiovanni L.G., et al. Eclamptic encephalopathy: imaging and pathogenetic considerations. Acta. Neurol. Scand. 1997, 96:277-282.
69. Mas J.L., Lamy C. Severe preeclampsia/eclampsia: hypertensive encephalopathy of pregnancy?. Cerebrovasc Dis. 1998, 8:53-58.
70. Mathy I., Gille M., Raemdonck F.V., et al. Neurological complications of intravenous immunoglobulin (IVIg) therapy: an illustrative case of acute encephalopathy following IVIg therapy and a review of the literature. Acta. Neurol. Belg. 1998, 98:347-351.
71. Matthys L.A., Coppage K.H., Lambers D.S., et al. Delayed postpartum preeclampsia: an experience of 151 cases. Am. J. Obstet. Gynecol 2004, 190:1464-1466.
72. McCoy S., Baldwin K. Pharmacotherapeutic options for the treatment of preeclampsia. Am. J. Health Syst. Pharm. 2009, 66:337-344.
73. McKinney A.M., Short J., Truwit C.L., et al. Posterior reversible encephalopathy syndrome: incidence of atypical regions of involvement and imaging findings. AJR Am. J. Roentgenol 2007, 189:904-912.
74. Milia A., Moller J., Pilia G., et al. Spinal cord involvement during hypertensive encephalopathy: clinical and radiological findings. J. Neurol. 2008, 255:142-143.
75. Moawad F.J., Hartzell J.D., Biega T.J., et al. Transient blindness due to posterior reversible encephalopathy syndrome following ephedra overdose. South Med. J. 2006, 99:511-514.
76. Mukherjee P., McKinstry R.C. Reversible posterior leukoencephalopathy syndrome: evaluation with diffusion-tensor MR imaging. Radiology 2001, 219:756-765.
77. Papadopoulos D.P., Mourouzis I., Thomopoulos C., et al. Hypertension Crisis 2010, 328-336. Blood Press, 19.
78. Pavlakis S.G., Frank Y., Chusid R. Hypertensive encephalopathy reversible occipitoparietal encephalopathy or reversible posterior leukoencephalopathy: three names for an old syndrome. J. Child Neurol. 1999, 14:277-281.
79. Perez M.I., Musini V.M. Pharmacological interventions for hypertensive emergencies: a Cochrane systematic review. J. Hum. Hypertens 2008, 22:596-607.
80. Popp M.B., Friedberg D.L., MacMillan B.G. Clinical characteristics of hypertension in burned children. Ann. Surg. 1980, 191:473-478.
81. Primavera A., Audenino D., Mavilio N., et al. Reversible posterior leucoencephalopathy syndrome in systemic lupus and vasculitis. Ann. Rheum. Dis. 2001, 60:534-537.
82. Provenzale J.M., Petrella J.R., Cruz L.C.H., et al. Quantitative assessment of diffusion abnormalities in posterior reversible encephalopathy syndrome. AJNR Am. J. Neuroradiol 2001, 22:1455-1461.
83. Rajasekhar A., George T.J. Gemcitabine-induced reversible posterior leukoencephalopathy syndrome: a case report and review of the literature. Oncologist. 2007, 12:1332-1335.
84. Richards A., Graham D., Bullock R. Clinicopathological study of neurological complications due to hypertensive disorders of pregnancy. J. Neurol Neurosurg Psychiatry 1988, 51:416-421.
85. Roberts J.M., Redman C.W.G. Pre-eclampsia: more than pregnancy-induced hypertension. Lancet 1993, 34:1447-1450.
86. Russell M.T., Nassif A.S., Cacayorin E.D., et al. Gemcitabine-associated posterior reversible encephalopathy syndrome: MR imaging and MR spectroscopy findings. Magn. Reson Imaging 2001, 19:129-132.
87. Schaefer P.W., Buonanno F.S., Gonzales R.G., et al. Diffusion-weighted imaging discriminates between cytotoxic and vasogenic edema in a patient with eclampsia. Stroke 1997, 28:1082-1085.
88. Schiff D., Lopes M.B. Neuropathological correlates of reversible posterior leukoencephalopathy. Neurocrit Care 2005, 2:303-305.
89. Schwartz R.B., Jones K.M., Kalina P., et al. Hypertensive encephalopathy: findings on CT MR imaging and SPECT imaging in 14 cases. AJR Am. J. Roentgenol 1992, 159:379-383.
90. Schwartz R.B., Bravo S.M., Klufas R.A., et al. Cyclosporine neurotoxicity and its relationship to hypertensive encephalopathy: CT and MR findings in 16 cases. AJR Am. J. Roentgenol 1995, 165:627-631.
91. Schwartz R.B., Mulkern R.V., Gudbjartsson H., et al. Diffusion-weighted MR imaging in hypertensive encephalopathy: clues to pathogenesis. AJNR Am. J. Neuroradiol 1998, 19:859-862.
92. Schwartz R.B., Feske S.K., Polak J.F., et al. Preeclampsia-eclampsia: clinical and neuroradiographic correlates and insights into the pathogenesis of hypertensive encephalopathy. Radiology 2000, 217:371-376.
93. Sengar A.R., Gupta R.K., Dhanuka A.K., et al. MR imaging MR angiography and MR spectroscopy of the brain in eclampsia. AJNR Am. J. Neuroradiol 1997, 18:1485-1490.
94. Sèze J.D., Mastain B., Stojkovic T., et al. Unusual MR findings of the brainstem in arterial hypertension. AJNR Am. J. Neuroradiol 2000, 21:391-394.
95. Sharer K., Benninger C., Heimann A., et al. Involvement of the central nervous system in renal hypertension. Eur. J. Pediatr. 1993, 152:59-63.
96. Sheth T.N., Ichise M., Kucharczyk W. Brain perfusion imaging in asymptomatic patients receiving cyclosporin. AJNR Am. J. Neuroradiol 1999, 20:853-856.
97. Sibai B., Dekker G., Kupferminc M. Pre-eclampsia. Lancet 2005, 365:785-799.
98. Singh N., Bonham A., Fukui M. Immunosuppressive-associated leukoencephalopathy in organ transplant recipients. Transplantation 2000, 69:467-472.
99. Singhal A.B. Postpartum angiopathy with reversible posterior leukoencephalopathy. Arch. Neurol. 2004, 61:411-416.
100. Slama M., Modeliar S.S. Hypertension in the intensive care unit. Curr. Opin. Cardiol 2006, 21:279-287.
101. Sofer S., Gueron M. Vasodilatation and hypertensive encephalopathy following scorpion envenomation in children. Chest 1990, 97:118-120.
102. Steinberg G., Khankin E.V., Karumanchi S.A. Angiogenic factors and preeclampsia. Thromb. Res. 2009, 123(Suppl 2):S93-S99.
103. Sticherling C., Bekerfeld J., Auch-Sohwelk, et al. Transient bilateral cortical blindness after coronary angiography. Lancet 1998, 351:570.
104. Strandgaard S., Paulson O.B. Cerebral autoregulation. Stroke 1984, 15:413-416.
105. Tallaksen C.M., Kerty E., Bakke S. Visual hallucinations in a case of reversible hypertension-induced brain oedema. Eur. J. Neurol. 1998, 5:615-618.
106. Taylor M.B., Jackson A., Weller J.R. Dynamic susceptibility contrast enhanced MRI in reversible posterior leukoencephalopathy syndrome associated with haemolytic uraemic syndrome. Br. J. Radiol. 2000, 73:438-442.
107. Thompson C.B., June C.H., Sullivan K.M., et al. Association between cyclosporin neurotoxicity and hypomagnesaemia. Lancet 1984, 2:1116-1120.
108. Trommer B., Homer D., Mikhael M. Cerebral vasospasm and eclampsia. Stroke 1988, 19:326-329.
109. Tsukimori K., Ochi H., Yumoto Y., et al. Reversible posterior encephalopathy syndrome followed by MR angiography-documented cerebral vasospasm in preeclampsia-eclampsia: report of 2 cases. Cerebrovasc Dis. 2008, 25:377-380.
110. van Mook W.N., Rennenberg R.J., Schurink G.W., et al. Cerebral hyperperfusion syndrome. Lancet Neurol. 2005, 4:877-888.
111. Varon J. The diagnosis and treatment of hypertensive crises. Postgrad Med. 2009, 121:5-13.
112. Vaughan C.J., Delanty N. Hypertensive emergencies. Lancet 2000, 356:411-417.
113. Vaughn C., Zhang L., Schiff D. Reversible posterior leukoencephalopathy syndrome in cancer. Curr. Oncol. Rep. 2008, 10:86-91.
114. Veltkamp R., Kupsch A., Polasek J., et al. Late onset postpartum eclampsia without pre-eclamptic prodromi: clinical and neuroradiological presentation in two patients. J. Neurol. Neurosurg Psychiatry 2000, 69:824-827.
115. Voltz R., Rosen F.V., Yousry T., et al. Reversible encephalopathy with cerebral vasospasm in a Guillain-Barré syndrome patient treated with intravenous immunoglobulin. Neurology 1996, 46:250-251.
116. Vora J., Cooper J., Thomas J.P. Polyarteritis nodosa presenting with hypertensive encephalopathy. Br. J. Clin. Pract. 1992, 46:144-145.
117. Wang M.C., Escott E.J., Breeze R.E. Posterior fossa swelling hydrocephalus resulting from hypertensive encephalopathy: case report and review of the literature. Neurosurgery 1999, 44:1325-1327.
118. Wang A., Rana S., Karumanchi S.A. Preeclampsia: the role of angiogenic factors in its pathogenesis. Physiology (Bethesda) 2009, 24:147-158.
119. Wartenberg K.E., Parra A. CT and CT-perfusion findings of reversible leukoencephalopathy during triple-H therapy for symptomatic subarachnoid hemorrhage-related vasospasm. J. Neuroimaging 2006, 16:170-175.
120. Wartenberg K.E., Patsalides A.D., Yepes M. Transient diffusion-weighted imaging changes in a patient with reversible leukoencephalopathy syndrome. Acta. Radiol. 2004, 45:674-678.
121. Weingarten K., Barbut D., Filippi C., et al. Acute hypertensive encephalopathy: findings on spin-echo and gradient-echo MR imaging. AJR Am. J. Roentgenol 1994, 162:665-670.
122. Will A., Lewis K., Hinshaw D., et al. Cerebral vasoconstriction in toxemia. Neurology 1987, 37:1555-1557.
123. Wong R., Beguelin G.Z., de Lima M., et al. Tacrolimus-associated posterior reversible encephalopathy syndrome after allogeneic hematopoietic stem cell transplantation. Br. J. Haematol 2003, 122:128-134.
124. Wu Q., Marescaux C., Wolff V., et al. Tacrolimus-associated posterior reversible encephalopathy syndrome after solid organtransplantation. Eur. Neurol. 2010, 64:169-177.